“Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan”. Dermatology Practical & Conceptual, vol. 14, no. 3, July 2024, p. e2024186, https://doi.org/10.5826/dpc.1403a186.